These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 25301291

  • 1. Efficacy of mycophenolate mofetil in sarcoidosis.
    Hamzeh N, Voelker A, Forssén A, Gottschall EB, Rose C, Mroz P, Maier LA.
    Respir Med; 2014 Nov; 108(11):1663-9. PubMed ID: 25301291
    [Abstract] [Full Text] [Related]

  • 2. Effect and safety of mycophenolate mofetil in chronic pulmonary sarcoidosis: a retrospective study.
    Brill AK, Ott SR, Geiser T.
    Respiration; 2013 Nov; 86(5):376-83. PubMed ID: 23295253
    [Abstract] [Full Text] [Related]

  • 3. A retrospective review of clinical features and treatment outcomes in steroid-resistant interstitial lung disease from polymyositis/dermatomyositis.
    Mira-Avendano IC, Parambil JG, Yadav R, Arrossi V, Xu M, Chapman JT, Culver DA.
    Respir Med; 2013 Jun; 107(6):890-6. PubMed ID: 23517887
    [Abstract] [Full Text] [Related]

  • 4. Mycophenolate mofetil for the treatment of scleritis.
    Sen HN, Suhler EB, Al-Khatib SQ, Djalilian AR, Nussenblatt RB, Buggage RR.
    Ophthalmology; 2003 Sep; 110(9):1750-5. PubMed ID: 13129873
    [Abstract] [Full Text] [Related]

  • 5. Mycophenolate mofetil in autoimmune hepatitis patients not responsive or intolerant to standard immunosuppressive therapy.
    Inductivo-Yu I, Adams A, Gish RG, Wakil A, Bzowej NH, Frederick RT, Bonacini M.
    Clin Gastroenterol Hepatol; 2007 Jul; 5(7):799-802. PubMed ID: 17509945
    [Abstract] [Full Text] [Related]

  • 6. Use of mycophenolate mofetil and azathioprine for the treatment of chronic hypersensitivity pneumonitis-A single-centre experience.
    Fiddler CA, Simler N, Thillai M, Parfrey H.
    Clin Respir J; 2019 Dec; 13(12):791-794. PubMed ID: 31464073
    [Abstract] [Full Text] [Related]

  • 7. Mycophenolate mofetil may be effective in CNS sarcoidosis but not in sarcoid myopathy.
    Androdias G, Maillet D, Marignier R, Pinède L, Confavreux C, Broussolle C, Vukusic S, Sève P.
    Neurology; 2011 Mar 29; 76(13):1168-72. PubMed ID: 21444902
    [Abstract] [Full Text] [Related]

  • 8. Mycophenolate mofetil as an alternative treatment in sarcoidosis.
    Papiris S, Stagaki E, Papadaki G, Kolilekas L, Korbila I, Apollonatou V, Kallieri M, Gialafos H, Chatziioannou S, Papaioannou AI, Manali ED.
    Pulm Pharmacol Ther; 2019 Oct 29; 58():101840. PubMed ID: 31518648
    [Abstract] [Full Text] [Related]

  • 9. Mycophenolate mofetil as a steroid-sparing agent in sarcoid-associated renal disease.
    Zaidi AA, DeVita MV, Michelis MF, Rosenstock JL.
    Clin Nephrol; 2015 Jan 29; 83(1):41-4. PubMed ID: 24075023
    [Abstract] [Full Text] [Related]

  • 10. Long-Term Treatment With Azathioprine and Mycophenolate Mofetil for Myositis-Related Interstitial Lung Disease.
    Huapaya JA, Silhan L, Pinal-Fernandez I, Casal-Dominguez M, Johnson C, Albayda J, Paik JJ, Sanyal A, Mammen AL, Christopher-Stine L, Danoff SK.
    Chest; 2019 Nov 29; 156(5):896-906. PubMed ID: 31238042
    [Abstract] [Full Text] [Related]

  • 11. Mycophenolate mofetil may serve as a steroid-sparing agent for sarcoidosis.
    Kouba DJ, Mimouni D, Rencic A, Nousari HC.
    Br J Dermatol; 2003 Jan 29; 148(1):147-8. PubMed ID: 12534610
    [Abstract] [Full Text] [Related]

  • 12. Use of Mycophenolate Mofetil or Azathioprine for the Management of Chronic Hypersensitivity Pneumonitis.
    Morisset J, Johannson KA, Vittinghoff E, Aravena C, Elicker BM, Jones KD, Fell CD, Manganas H, Dubé BP, Wolters PJ, Collard HR, Ryerson CJ, Ley B.
    Chest; 2017 Mar 29; 151(3):619-625. PubMed ID: 27816444
    [Abstract] [Full Text] [Related]

  • 13. Clinical observations of mycophenolate mofetil therapy in refractory primary nephrotic syndrome.
    Zhao M, Chen X, Chen Y, Liu Z, Liu Y, Lu F, Zhang Y, Wang H.
    Nephrology (Carlton); 2003 Jun 29; 8(3):105-9. PubMed ID: 15012724
    [Abstract] [Full Text] [Related]

  • 14. Combination therapy with mycophenolate mofetil and prednisone in steroid-resistant idiopathic membranoproliferative glomerulonephritis.
    Yuan M, Zou J, Zhang X, Liu H, Teng J, Zhong Y, Ding X.
    Clin Nephrol; 2010 May 29; 73(5):354-9. PubMed ID: 20420795
    [Abstract] [Full Text] [Related]

  • 15. Mycophenolate Mofetil Combined With Prednisone Versus Full-Dose Prednisone in IgA Nephropathy With Active Proliferative Lesions: A Randomized Controlled Trial.
    Hou JH, Le WB, Chen N, Wang WM, Liu ZS, Liu D, Chen JH, Tian J, Fu P, Hu ZX, Zeng CH, Liang SS, Zhou ML, Zhang HT, Liu ZH.
    Am J Kidney Dis; 2017 Jun 29; 69(6):788-795. PubMed ID: 28215945
    [Abstract] [Full Text] [Related]

  • 16. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].
    Kwinta-Rybicka J, Wilkosz K, Wierzchowska-Słowiacze EK, Ogarek I, Moczulska A, Stec Z, Pełkowska A, Sancewicz-Pach K, Pietrzyk JA.
    Przegl Lek; 2006 Jun 29; 63 Suppl 3():44-8. PubMed ID: 16898486
    [Abstract] [Full Text] [Related]

  • 17. A comparison of a standard-dose prednisone regimen and mycophenolate mofetil combined with a lower prednisone dose in Chinese adults with idiopathic nephrotic syndrome who were carriers of hepatitis B surface antigen: a prospective cohort study.
    Li X, Tian J, Wu J, He Q, Li H, Han F, Li Q, Chen Y, Ni Q, Chen J.
    Clin Ther; 2009 Apr 29; 31(4):741-50. PubMed ID: 19446147
    [Abstract] [Full Text] [Related]

  • 18. Effect of mycophenolate mofetil on pulmonary function in scleroderma-associated interstitial lung disease.
    Gerbino AJ, Goss CH, Molitor JA.
    Chest; 2008 Feb 29; 133(2):455-60. PubMed ID: 18071023
    [Abstract] [Full Text] [Related]

  • 19. Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome.
    Bagga A, Hari P, Moudgil A, Jordan SC.
    Am J Kidney Dis; 2003 Dec 29; 42(6):1114-20. PubMed ID: 14655181
    [Abstract] [Full Text] [Related]

  • 20. Mycophenolate mofetil in steroid/cyclosporine-dependent/resistant nephrotic syndrome.
    Mendizábal S, Zamora I, Berbel O, Sanahuja MJ, Fuentes J, Simon J.
    Pediatr Nephrol; 2005 Jul 29; 20(7):914-9. PubMed ID: 15891923
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.